Two Sigma Investments’s Aura Biosciences AURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-27,512
Closed -$226K 3198
2024
Q4
$226K Sell
27,512
-6,911
-20% -$65K ﹤0.01% 2837
2024
Q3
$307K Sell
34,423
-51,860
-60% -$445K ﹤0.01% 2659
2024
Q2
$652K Sell
86,283
-27,606
-24% -$202K ﹤0.01% 2229
2024
Q1
$894K Buy
113,889
+71,502
+169% +$593K ﹤0.01% 2019
2023
Q4
$376K Buy
+42,387
New +$359K ﹤0.01% 2597

Other funds holding AURA

Two Sigma Investments's AURA Position: Q1 2025 in Review

Two Sigma Investments sold out of Aura Biosciences (AURA) in Q1 2025, closing a stake of 27,512 shares — an estimated $226K sold.

Two Sigma Investments first reported a position in AURA in Q4 2023 and held it in 5 quarters. The position peaked at $894K in Q1 2024. 94 funds tracked by Wall St. Rank hold AURA as of Q1 2025.

  • Two Sigma Investments reported no remaining Aura Biosciences position as of Q1 2025 after selling out during the quarter.
  • Two Sigma Investments sold 27,512 Aura Biosciences shares in Q1 2025, an estimated $226K.
  • Two Sigma Investments first reported a position in Aura Biosciences in Q4 2023 and held it in 5 quarters.
  • Two Sigma Investments's Aura Biosciences position peaked at $894K in Q1 2024.
  • 94 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2025.

Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.